Haagen IA - Search Results

1

Analytical validation of the Hevylite assays for M-protein quantification.

Jacobs JFM, Haagen IA, Lodder A, van der Kroft C, de Kat Angelino CM, Croockewit S, Nieuwenhuys E, Gelderman KA. Jacobs JFM, et al. Among authors: haagen ia. Clin Chem Lab Med. 2018 Jun 27;56(7):1169-1175. doi: 10.1515/cclm-2017-0817. Clin Chem Lab Med. 2018. PMID: 29397379

2

Clinically relevant discrepancies between different rheumatoid factor assays.

Falkenburg WJJ, von Richthofen HJ, Koers J, Weykamp C, Schreurs MWJ, Bakker-Jonges LE, Haagen IA, Lems WF, Hamann D, van Schaardenburg D, Rispens T. Falkenburg WJJ, et al. Among authors: haagen ia. Clin Chem Lab Med. 2018 Sep 25;56(10):1749-1758. doi: 10.1515/cclm-2017-0988. Clin Chem Lab Med. 2018. PMID: 29427550 Free article. No abstract available.

3

NUMBER: standardized reference intervals in the Netherlands using a 'big data' approach.

den Elzen WPJ, Brouwer N, Thelen MH, Le Cessie S, Haagen IA, Cobbaert CM. den Elzen WPJ, et al. Among authors: haagen ia. Clin Chem Lab Med. 2018 Dec 19;57(1):42-56. doi: 10.1515/cclm-2018-0462. Clin Chem Lab Med. 2018. PMID: 30218599 Free article.

4

Allergy: Evaluation of 16 years (2007-2022) results of the shared external quality assessment program in Belgium, Finland, Portugal and The Netherlands.

Heron M, Schreurs MWJ, Haagen IA, China B, Faria AP, Vanhanen AR, Thelen M, Weykamp CW. Heron M, et al. Among authors: haagen ia. Clin Chem Lab Med. 2023 Nov 28. doi: 10.1515/cclm-2023-0862. Online ahead of print. Clin Chem Lab Med. 2023. PMID: 38008748

5

Interaction of human monocyte Fc gamma receptors with rat IgG2b. A new indicator for the Fc gamma RIIa (R-H131) polymorphism.

Haagen IA, Geerars AJ, Clark MR, van de Winkel JG. Haagen IA, et al. J Immunol. 1995 Feb 15;154(4):1852-60. J Immunol. 1995. PMID: 7836769

6

Direct sodium measurement prevents underestimation of hyponatremia in critically ill patients.

van den Ancker W, Haagen IA, van der Voort PH. van den Ancker W, et al. Among authors: haagen ia. Intensive Care Med. 2015 Mar;41(3):553-4. doi: 10.1007/s00134-014-3623-y. Epub 2015 Feb 12. Intensive Care Med. 2015. PMID: 25672273 No abstract available.

7

The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2.

Haagen IA, Geerars AJ, de Lau WB, Bast BJ, de Gast BC. Haagen IA, et al. Blood. 1995 Jun 1;85(11):3208-12. Blood. 1995. PMID: 7538821 Free article.

8

Killing of human leukaemia/lymphoma B cells by activated cytotoxic T lymphocytes in the presence of a bispecific monoclonal antibody (alpha CD3/alpha CD19).

Haagen IA, van de Griend R, Clark M, Geerars A, Bast B, de Gast B. Haagen IA, et al. Clin Exp Immunol. 1992 Dec;90(3):368-75. doi: 10.1111/j.1365-2249.1992.tb05853.x. Clin Exp Immunol. 1992. PMID: 1281055 Free PMC article.

9

Unprimed CD4+ and CD8+ T cells can be rapidly activated by a CD3 x CD19 bispecific antibody to proliferate and become cytotoxic.

Haagen IA, de Lau WB, Bast BJ, Geerars AJ, Clark MR, de Gast BC. Haagen IA, et al. Cancer Immunol Immunother. 1994 Dec;39(6):391-6. doi: 10.1007/BF01534426. Cancer Immunol Immunother. 1994. PMID: 7528094 Free PMC article.

10

CD8 T cell activation after intravenous administration of CD3 x CD19 bispecific antibody in patients with non-Hodgkin lymphoma.

de Gast GC, Haagen IA, van Houten AA, Klein SC, Duits AJ, de Weger RA, Vroom TM, Clark MR, Phillips J, van Dijk AJ, et al. de Gast GC, et al. Among authors: haagen ia. Cancer Immunol Immunother. 1995 Jun;40(6):390-6. doi: 10.1007/BF01525390. Cancer Immunol Immunother. 1995. PMID: 7543021 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page